Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled phase 3 trial - LeWitt, P A; Hauser, R A; Pahwa, R (Lancet Neurol, 2019)